Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects.

Chaoul N, Albanesi M, Giliberti L, Rossi MP, Nettis E, Di Bona D, Caiaffa MF, Macchia L.

Int Arch Allergy Immunol. 2019;179(1):37-42. doi: 10.1159/000496436. Epub 2019 Mar 28.

PMID:
30921804
2.

Immunological characterization of onion (Allium cepa) allergy.

Albanesi M, Pasculli C, Giliberti L, Rossi MP, Di Bona D, Caiaffa MF, Macchia L.

Postepy Dermatol Alergol. 2019 Feb;36(1):98-103. doi: 10.5114/ada.2019.82829. Epub 2019 Feb 22.

3.

Delayed allergy to acyclovir revealed by lymphocyte proliferation test.

Albanesi M, Di Girolamo A, Aresta V, Rossi MP, Giliberti L, Perrone T, Di Bona D, Caiaffa MF, Specchia G, Macchia L.

Postepy Dermatol Alergol. 2018 Oct;35(5):527-529. doi: 10.5114/ada.2018.77244. Epub 2018 Jul 19. No abstract available.

4.

Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: a case report.

Di Girolamo A, Albanesi M, Sinisi A, Nettis E, Di Bona D, Caiaffa MF, Macchia L.

Clin Mol Allergy. 2018 Oct 29;16:22. doi: 10.1186/s12948-018-0100-0. eCollection 2018.

5.

Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review.

Di Bona D, Frisenda F, Albanesi M, Di Lorenzo G, Caiaffa MF, Macchia L.

Clin Exp Allergy. 2018 Nov;48(11):1391-1401. doi: 10.1111/cea.13242. Epub 2018 Sep 4. Review.

PMID:
30079619
6.

Importance of Specific IgE/Total IgE Ratio in Disambiguating Amoxicillin Allergy Diagnosis in a Real-Life Setting.

Albanesi M, Sinisi A, Frisenda F, Di Bona D, Caiaffa MF, Macchia L.

Int Arch Allergy Immunol. 2018;177(2):167-169. doi: 10.1159/000489705. Epub 2018 Jun 19. No abstract available.

PMID:
29920499
7.

A desensitization protocol for delayed allergy to cytarabine: analysis of two cases.

Albanesi M, Carluccio P, Nico A, Giliberti L, Di Bona D, Caiaffa MF, Specchia G, Macchia L.

Postepy Dermatol Alergol. 2018 Apr;35(2):222-224. doi: 10.5114/ada.2018.75249. Epub 2018 Apr 24. No abstract available.

8.

A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy.

Albanesi M, Nico A, Sinisi A, Giliberti L, Rossi MP, Rossini M, Kourtis G, Rucco AS, Loconte F, Muolo L, Zurlo M, Di Bona D, Caiaffa MF, Macchia L.

Clin Mol Allergy. 2018 Jan 18;16:2. doi: 10.1186/s12948-017-0079-y. eCollection 2018.

9.

Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.

Di Bona D, Fiorino I, Taurino M, Frisenda F, Minenna E, Pasculli C, Kourtis G, Rucco AS, Nico A, Albanesi M, Giliberti L, D'Elia L, Caiaffa MF, Macchia L.

Respir Med. 2017 Sep;130:55-60. doi: 10.1016/j.rmed.2017.07.013. Epub 2017 Jul 19.

PMID:
29206634
10.

KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.

Di Bona D, Aiello A, Colomba C, Bilancia M, Accardi G, Rubino R, Giannitrapani L, Tuttolomondo A, Cascio A, Caiaffa MF, Rizzo S, Di Lorenzo G, Candore G, Duro G, Macchia L, Montalto G, Caruso C; KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group.

J Viral Hepat. 2017 Sep;24(9):768-775. doi: 10.1111/jvh.12698. Epub 2017 May 5.

PMID:
28211154
11.

Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera).

Di Bona D, Albanesi M, Giliberti LA, Nico A, Rossi MP, Caiaffa MF, Macchia L.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):821-822. doi: 10.1016/j.jaip.2016.09.044. Epub 2016 Nov 23. No abstract available.

PMID:
27888036
12.

Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases.

Fiorino I, Loconte F, Rucco AS, Nico A, Vacca M, Damiani E, Nettis E, Caiaffa MF, Macchia L.

Postepy Dermatol Alergol. 2014 Oct;31(5):332-4. doi: 10.5114/pdia.2014.44023. Epub 2014 Oct 22. No abstract available.

13.

Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.

Novelli F, Latorre M, Vergura L, Caiaffa MF, Camiciottoli G, Guarnieri G, Matucci A, Macchia L, Vianello A, Vultaggio A, Celi A, Cazzola M, Paggiaro P; Xolair Italian Study Group.

Pulm Pharmacol Ther. 2015 Apr;31:123-9. doi: 10.1016/j.pupt.2014.09.007. Epub 2014 Sep 30.

PMID:
25281265
14.

Tako-tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration.

Santoro F, Correale M, Ieva R, Caiaffa MF, Pappalardo I, Di Biase M, Brunetti ND.

Int J Cardiol. 2012 Aug 9;159(1):e20-1. doi: 10.1016/j.ijcard.2011.11.106. Epub 2012 Jan 5. No abstract available.

PMID:
22225762
15.

Retrospective monitoring in the management of persistent asthma.

Kourtis G, Caiaffa MF, Forte C, Scarlato MI, Macchia L.

Respir Care. 2011 May;56(5):633-43. doi: 10.4187/respcare.00796. Epub 2011 Jan 27.

16.

Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy.

Kourtis G, Rucco AS, Loconte F, Caiaffa MF, Macchia L.

J Investig Allergol Clin Immunol. 2010;20(5):451-2. No abstract available.

17.

Italian real-life experience of omalizumab.

Cazzola M, Camiciottoli G, Bonavia M, Gulotta C, Ravazzi A, Alessandrini A, Caiaffa MF, Berra A, Schino P, Di Napoli PL, Maselli R, Pelaia G, Bucchioni E, Paggiaro PL, Macchia L.

Respir Med. 2010 Oct;104(10):1410-6. doi: 10.1016/j.rmed.2010.04.013. Epub 2010 May 18.

18.

Skin testing technique and precision in stinging insect allergy.

Corallino M, Nico A, Kourtis G, Caiaffa MF, Macchia L.

J Clin Nurs. 2007 Jul;16(7):1256-64.

PMID:
17584343
19.

Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast.

Ramires R, Caiaffa MF, Tursi A, Haeggström JZ, Macchia L.

Biochem Biophys Res Commun. 2004 Nov 12;324(2):815-21.

PMID:
15474500
20.

Cyclooxygenase-2 expression in oral squamous cell carcinoma.

Pannone G, Bufo P, Caiaffa MF, Serpico R, Lanza A, Lo Muzio L, Rubini C, Staibano S, Petruzzi M, De Benedictis M, Tursi A, De Rosa G, Macchia L.

Int J Immunopathol Pharmacol. 2004 Sep-Dec;17(3):273-82.

PMID:
15461861
21.

Systemic adverse reaction to diclofenac administered by transdermal iontophoresis.

Macchia L, Caiaffa MF, di Gioia R, Tursi A.

Allergy. 2004 Mar;59(3):367-8. No abstract available.

PMID:
14982530
22.

Fig and mulberry cross-allergy.

Caiaffa MF, Cataldo VM, Tursi A, Macchia L.

Ann Allergy Asthma Immunol. 2003 Nov;91(5):493-5.

PMID:
14692435
23.

Grape anaphylaxis.

Caiaffa MF, Tursi A, Macchia L.

J Investig Allergol Clin Immunol. 2003;13(3):211-2.

PMID:
14635473
24.

Beauvericin cytotoxicity to the invertebrate cell line SF-9.

Calo' L, Fornelli F, Nenna S, Tursi A, Caiaffa MF, Macchia L.

J Appl Genet. 2003;44(4):515-20.

PMID:
14617831
25.

Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin.

Calò L, Fornelli F, Ramires R, Nenna S, Tursi A, Caiaffa MF, Macchia L.

Pharmacol Res. 2004 Jan;49(1):73-7.

PMID:
14597155
26.

General adverse reaction to aspirin administered by transdermal iontophoresis.

Macchia L, Caiaffa MF, Vacca A, Tursi A.

Eur J Clin Pharmacol. 2002 Dec;58(9):641-2. No abstract available.

PMID:
12602340
27.

Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen.

Macchia L, Caiaffa MF, Di Paola R, De Michele G, Bariletto G, Iudice A, Tursi A.

Pharmacol Res. 2001 Dec;44(6):461-6.

PMID:
11735351
28.

5-Lipoxygenase upregulation by dexamethasone in human mast cells.

Colamorea T, Di Paola R, Macchia F, Guerrese MC, Tursi A, Butterfield JH, Caiaffa MF, Haeggström JZ, Macchia L.

Biochem Biophys Res Commun. 1999 Nov 30;265(3):617-24.

PMID:
10600470
29.

Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term.

Macchia L, Di Paola R, Guerrese MC, Chiechi LM, Tursi A, Caiaffa MF, Haeggstrom JZ.

Biochem Biophys Res Commun. 1997 Apr 17;233(2):496-501.

PMID:
9144565
30.

Fusaproliferin production by Fusarium subglutinans and its toxicity to Artemia salina, SF-9 insect cells, and IARC/LCL 171 human B lymphocytes.

Logrieco A, Moretti A, Fornelli F, Fogliano V, Ritieni A, Caiaffa MF, Randazzo G, Bottalico A, Macchia L.

Appl Environ Microbiol. 1996 Sep;62(9):3378-84.

31.

Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components.

Di Felice G, Caiaffa MF, Bariletto G, Afferni C, Di Paola R, Mari A, Palumbo S, Tinghino R, Sallusto F, Tursi A, et al.

J Allergy Clin Immunol. 1994 Sep;94(3 Pt 1):547-55.

PMID:
8083460
32.

Olive pollen allergy in Bari, Italy.

Macchia L, Caiaffa MF, Tursi A.

Allergy. 1993 Oct;48(7):551. No abstract available.

PMID:
8238815
33.

Airborne Cupressaceae pollen in southern Italy.

Caiaffa MF, Macchia L, Strada S, Bariletto G, Scarpelli F, Tursi A.

Ann Allergy. 1993 Jul;71(1):45-50.

PMID:
8328713
34.

Purification and fine characterization of a major allergen from Olea europaea pollen extract.

De Cesare F, Pini C, Di Felice G, Caiaffa MF, Macchia L, Tursi A, Tinghino R, Palumbo S, Sallusto F, Federico R.

Allergy. 1993 May;48(4):248-54.

PMID:
8328660
35.

Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever.

Caiaffa MF, Iudice A, Macchia L, Tursi A, Vergallo G, Sacerdoti G, Venuti A, Della Torre F, Musarra A.

J Investig Allergol Clin Immunol. 1992 May-Jun;2(3):162-6.

PMID:
1342896
36.

Changes in skin reactivity, specific IgE and IgG levels after one year of immunotherapy in olive pollinosis.

Macchia L, Caiaffa MF, Di Felice G, Pini C, Bariletto G, Strada S, Tursi A.

Allergy. 1991 Aug;46(6):410-8.

PMID:
1957991
37.

Monitoring of atmospheric conditions and forecast of olive pollen season.

Macchia L, Aliani M, Caiaffa MF, Carbonara AM, Gatti E, Iacobelli A, Strada S, Casella G, Tursi A.

Experientia Suppl. 1987;51:95-9. No abstract available.

PMID:
2958358

Supplemental Content

Loading ...
Support Center